Amarin CEO says investors should ‘understand’ the data as stock drops

Amarin CEO John Thero shrugged off the stock’s decline on Monday, telling CNBC that any investor concerned about its latest clinical trial should take a better look at the data.

Meg Tirrell
contributed to this report.

Source link

Leave a Comment

At least 20 dead in blasts at sports center in Afghan capitalNorthern Ireland child post-mortem examinations to be done in England